97 related articles for article (PubMed ID: 1912514)
1. MHC antigen expression in colorectal tumours.
Smith ME
Semin Cancer Biol; 1991 Feb; 2(1):17-21. PubMed ID: 1912514
[TBL] [Abstract][Full Text] [Related]
2. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
3. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
[TBL] [Abstract][Full Text] [Related]
5. The role of MHC class I expression in developmental tumours.
Stern PL; Rinke de Wit TF
Semin Cancer Biol; 1991 Feb; 2(1):11-6. PubMed ID: 1912513
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
9. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
10. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HLA class I gene expression in human colorectal carcinoma.
Soong TW; Oei AA; Hui KM
Semin Cancer Biol; 1991 Feb; 2(1):23-33. PubMed ID: 1912515
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen expression by peritoneal macrophages from women with pelvic endometriosis is depressed but coordinated with costimulatory molecule expression.
Kusume T; Maeda N; Izumiya C; Yamamoto Y; Hayashi K; Oguri H; Nishimori Y; Fukaya T
Fertil Steril; 2005 Apr; 83 Suppl 1():1232-40. PubMed ID: 15831297
[TBL] [Abstract][Full Text] [Related]
13. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
14. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
Maccalli C; Di Cristanziano V; Fodale V; Corsi D; D'Agostino G; Petrangeli V; Laurenti L; Guida S; Mazzocchi A; Arienti F; Perrone MP; Castelli C; Rivoltini L; Zagonel V; Tartaglia M; Parmiani G; Belardelli F
Clin Cancer Res; 2008 Nov; 14(22):7292-303. PubMed ID: 18974390
[TBL] [Abstract][Full Text] [Related]
15. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma induces HLA-DR expression by thyroid epithelium.
Todd I; Pujol-Borrell R; Hammond LJ; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1985 Aug; 61(2):265-73. PubMed ID: 3930110
[TBL] [Abstract][Full Text] [Related]
17. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
18. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
19. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
20. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
Stemme S; Fager G; Hansson GK
Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]